Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
lauren.watson@paediatrics.ox.ac.uk

Lauren Watson

Post Doctoral Researcher

I am currently developing a stem cell-based model to test the safety and efficacy of oligonucleotide therapies for Myotonic Dystrophy Type 1.

Recent publications

Neurodegeneration in SCA14 is associated with increased PKCγ kinase activity, mislocalization and aggregation.

Wong MMK. et al, (2018), Acta Neuropathol Commun, 6

A Simplified Method for Generating Purkinje Cells from Human-Induced Pluripotent Stem Cells.

Watson LM. et al, (2018), Cerebellum, 17, 419 - 427

Dominant Mutations in GRM1 Cause Spinocerebellar Ataxia Type 44.

Watson LM. et al, (2017), Am J Hum Genet, 101

Dominant Mutations in GRM1 Cause Spinocerebellar Ataxia Type 44.

Watson LM. et al, (2017), Am J Hum Genet, 101

Dominant Mutations in GRM1 Cause Spinocerebellar Ataxia Type 44.

Watson LM. et al, (2017), Am J Hum Genet, 101, 451 - 458